Hepsiburada Announces Second Quarter 2026 Financial Results
Near-term HEPS likely pressured by inflation restatement and margin compression; watch for GMV/mix improvements in 2H24Q.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Near-term HEPS likely pressured by inflation restatement and margin compression; watch for GMV/mix improvements in 2H24Q.
What happened and why it matters
HEPS reported Q2 2026 results restated under IAS 29 inflation accounting, highlighting inflation-adjusted metrics. Revenue rose 3.1% to 22.81B TRY with GMV of 56.7B TRY, but net loss widened to 1.89B TRY as opex rose. EBITDA was only 0.4% of GMV, while a fintech initiative contributed modest GMV; profitability remains challenged near term.
Inflation restatement (IAS 29) adds a layer of earnings distortion, complicating comps and potentially pressuring the stock on a per-share basis. The quarter showed a widening net loss and margin compression, which historically weighs on near-term equity performance. While GMV and 3P revenue offer some positives, the combination of higher opex, weak EBITDA margin, and a major shareholder change risk (Kaspi) could sustain negative sentiment until profitability improves.
Hepsiburada restates Q2 2026 results under IAS 29 hyperinflation rules.
Q2 revenue up 3.1% to 22.81B TRY; GMV at 56.7B TRY.
Net loss for Q2 2026: 1.89B TRY; H1 net loss: 2.95B.
EBITDA margin shrank to 0.4% of GMV; H1 margin 0.6%.
Cash at 6/30: about 7.0B TRY; Q2 free cash flow: 1.55B TRY.
Earnings: Hepsiburada’s Q2 restatement and reported HEPS trajectory anchor the category; the inflation-adjusted disclosures and cash-flow dynamics drive valuation and near-term price action.
More AI-analyzed coverage connected to this story